THE ARISING · DAILY EDITION
The Arising — October 31, 2026
Download the PDF ↓Longevity & Healthspan
Fewer terrifying COPD flare-ups: two trials put an inflammatory target to a meaningful test
Reading medical evidence →The liver test that could spare a biopsy—but only for the question it answers well
Longevity in daily life →After lung-cancer chemoradiation, a second drug raised the harm without proving the extra benefit
Reading medical evidence →A 17-point absolute difference in leukemia relapse deserves attention—and close transplant scrutiny
Reading medical evidence →The AI inbox paradox: writing a reply faster does not necessarily give clinicians their evenings back
Reading medical evidence →The evidence review can fail before the statistics begin
Longevity in daily life →A psychedelic trial's most important result may be the outcome it missed
Reading medical evidence →Sophisticated exercise personalization changed the laboratory profile—not the functional result
Strength and function →The sleep study that makes thirty seconds look like an arbitrary boundary
Sleep →A virus found in the human gut turns out to infect a bacterium—not necessarily the person
Longevity in daily life →